犬尿氨酸
犬尿氨酸 性质
| 沸点 | 466.6±45.0 °C(Predicted) |
|---|---|
| 密度 | 1.343±0.06 g/cm3(Predicted) |
| 储存条件 | 2-8°C |
| 溶解度 | 水：5.0（最大浓度 mg/mL）；24.01（最大浓度 mM） |
| 形态 | 结晶固体 |
| 酸度系数(pKa) | 2.21±0.23(Predicted) |
| 颜色 | 浅黄至黄色 |
| 旋光度 (Optical Rotation) | Consistent with structure |
| 主要应用 | 细胞分析 |
| InChI | 1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m1/s1 |
| InChIKey | YGPSJZOEDVAXAB-MRVPVSSYSA-N |
| SMILES | N[C@H](CC(=O)c1ccccc1N)C(O)=O |
| CAS 数据库 | 13441-51-5(CAS DataBase Reference) |
犬尿氨酸 用途与合成方法
|
Human Endogenous Metabolite
|
D-kynurenine (10, 40, 60, and 100 µM) positively regulates the metastasis of 95D cells, a lung cancer cell line, which is reduced upon siRNAAhr treatment. Significant enhancement VIM expression was detected in the presence of D-kynurenine (10 and 40 µM). 10 µM D-kynurenine markedly attenuates E-cadherin level. 10 µM D-kynurenine-mediated changes of VIM and E-cadherin are substantially attenuated on siRNAAhr treatment as well. The evidences-10/40 µM D-kynurenine-induced up-regulation of CYP1A1, 10 µM D-kynurenine-induced increase of nuclear transfer of Ahr, and 10/40/60/100 µM D-kynurenine-induced enhancement of DER-luciferase activity-indicated that D-kynurenine Is capable of activating Ahr in fact.
犬尿氨酸 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | HY-W014502R | 犬尿氨酸 | 13441-51-5 | 5 mg | 600 |
| 2026-09-15 | HY-W014502R | 犬尿氨酸 | 13441-51-5 | 10 mg | 950 |
